Barely Significant
← all excerpts

Novel Oral Anticoagulants for Venous Thromboembolism with Special Emphasis on Risk of Hemorrhagic Complications and Reversal Agents.

Curr Drug ther · 2016 · PMC5003057 · PMID 27594818

1
hedged sentence
closest p
boldest claim

The sentences

The RE-COVER pooled analysis of the double dummy period (only the time when dabigatran was taken by the study group) revealed a reduction in major bleeding which almost reached statistical significance [ 17 ].

also in 378 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.